The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Access · International

Personal import allowances, compared

Wiki
BA
b.adeyemiTL216 Dec 2025#1
Community wiki post. Any member at trust level 3 or above can edit this post; every edit is recorded. Last edited by a.reyes on 21 Apr 2026.
  • 16 Mar 2026 — g.pemberton_uk: Added the worked example and a unit label to the table header.
  • 29 Jan 2026 — PharmNotes_Whitfield: Clarified the distinction that was causing repeat questions below.
  • 21 Apr 2026 — a.reyes: Removed a claim that the cited source did not support.
Editors: g.pemberton_uk, PharmNotes_Whitfield, a.reyes, j.delacroix

On the subject in the title: Personal import allowances, compared Working notes rather than a conclusion.

I have spent a fortnight trying to pin personal import allowances down and I want to set out where I have got to, because I suspect the honest answer is duller than the thread this will produce.

What I have: a consistent observation across a small number of cases, collected the same way each time. What I do not have: any controlled comparison, or any reason to think my cases are representative.

The specific question is whether the pattern survives once the obvious confounder is removed. I cannot remove it with what I have.

0 likes 7mo
N
NardoneTL2Member17 Dec 2025#2

A definition problem is doing most of the work in this personal import allowances discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is left is small.

3 likes 7mo
NK
n.kaufmannTL218 Dec 2025#3

What I would check first on personal import allowances is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.

11 likes 7mo
AK
a.kwiatkowskiTL2Member18 Dec 2025#4
n.kaufmann, post #3: What I would check first on personal import allowances is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph. Go to post

On the opening post — agreed on the reasoning, with one qualification.

Nothing here is legal advice, and in this subcategory that caveat is doing real work rather than sitting decoratively at the end.

23 likes in reply to #3 7mo
SC
s.chowdhuryTL3Regular19 Dec 2025#5

Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before ordering is prudent.

I keep a log of this specifically because memory is unreliable about it.

0 likes 7mo
I
IRenaudinTL2Member20 Dec 2025 · edited#6

Import rules for personal quantities are jurisdiction-specific and change without much publicity. Establishing your own position is unavoidable.

One case, stated as one case.

1 like 7mo
EB
e.bakkenTL220 Dec 2025#7

Reading rather than contributing, but this is the most useful thread I have found on it.

0 likes 7mo
MM
methods_marginTL3Regular21 Dec 2025#8
IRenaudin, post #6: Import rules for personal quantities are jurisdiction-specific and change without much publicity. Establishing your own position is unavoidable. One case, stated as one case. Go to post

Worth separating two things that post #4 runs together.

On personal import allowances, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.

3 likes in reply to #6 7mo
NB
n.boatengTL221 Dec 2025#9
e.bakken, post #7: Reading rather than contributing, but this is the most useful thread I have found on it. Go to post

Adding what did not work for me on personal import allowances, since the failures never get written up and they are half the useful information.

3 likes in reply to #7 7mo
CR
crossover_reviewTL3Regular22 Dec 2025#10

Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union; tirzepatide approved in some but not all; retatrutide approved nowhere yet (ongoing trials).

10 likes 7mo

Suggested topics

TopicParticipantsRepliesViewsActivity
Second pass at: Cross-border purchase within the EU: the actual rules
Posting this under the heading it deserves: Second pass at: Cross-border purchase within the EU: the actual rules Everything below is what sits behind that. The question about Cross-border purchase within…
KVMSZILOWM+135 139 8.7k 16mo
Revisiting: Language barriers in accessing a prescription abroad
Posting this under the heading it deserves: Revisiting: Language barriers in accessing a prescription abroad Everything below is what sits behind that. Asking about Language barriers in accessing on behalf of…
MMLSSLMIMH+131 148 28k 5mo
About the International category
Country-by-country availability and legality, dated because it changes constantly. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author…
TVDOPMAN+6 11 240 22mo
Language barriers in accessing a prescription abroad
Language barriers in accessing a prescription abroad Writing it up because I had to work it out twice and would rather nobody else did. I was wrong about language barriers in accessing in a thread last spring…
KBMAMR 2 22k 1h
What changed in 2026, by region
What changed in 2026, by region — that is the question, and I have not found it answered plainly anywhere I have looked. Documenting an access outcome, dated, because everything in this category expires. As…
AFNDCNNNID+110 122 1.4k 18mo

Related topics — sharing the tags EMA, MHRA, telehealth

TopicParticipantsRepliesViewsActivity
Coming back to: Cross-border purchase rules within the EU
Cross-border purchase rules within the EU Writing it up because I had to work it out twice and would rather nobody else did. Cross-border purchase rules within — I have the observation and I do not trust my…
JEDBNRPFFE+12 16 2.8k 11mo
Second pass at: When your prescriber and the evidence disagree
Second pass at: When your prescriber and the evidence disagree — setting out what I have, and where I think it stops being reliable. What changes if the standard account of prescriber is wrong? I ask because…
BNMONRPFB+51 55 9.2k 2d
MHRA statements, read directly
MHRA statements, read directly Writing it up because I had to work it out twice and would rather nobody else did. Asking about MHRA statements directly, because I have read four threads on it and each…
VMSOGHTVJ+93 101 2.2k 5mo
Second pass at: Import rules for personal quantities, by jurisdiction, dated
Second pass at: Import rules for personal quantities, by jurisdiction, dated Writing it up because I had to work it out twice and would rather nobody else did. Asking what a regulator's document actually…
DHKAV 2 5k 11mo
Discussing something you have already been doing — the long version
Discussing something you have already been doing — the long version Writing it up because I had to work it out twice and would rather nobody else did. A question about how to describe something to a clinician…
ITATALENG+14 18 58k 12mo